Structure-antitumor activity relationships among quinone derivatives

Cancer Chemother Rep 2. 1974 Apr;4(2):1-362.
No abstract available

MeSH terms

  • Animals
  • Anthraquinones / therapeutic use
  • Antineoplastic Agents / therapeutic use*
  • Azirines / therapeutic use
  • Bridged-Ring Compounds / therapeutic use
  • Carcinoma 256, Walker / drug therapy
  • Daunorubicin / therapeutic use
  • Drug Evaluation, Preclinical
  • Heterocyclic Compounds / therapeutic use
  • L-Lactate Dehydrogenase / blood
  • Leukemia L1210 / drug therapy
  • Mice
  • Mitomycins / therapeutic use
  • Naphthoquinones / therapeutic use
  • Neoplasms, Experimental / drug therapy
  • Quinones / therapeutic use*
  • Sarcoma 180 / drug therapy
  • Streptonigrin / therapeutic use
  • Structure-Activity Relationship

Substances

  • Anthraquinones
  • Antineoplastic Agents
  • Azirines
  • Bridged-Ring Compounds
  • Heterocyclic Compounds
  • Mitomycins
  • Naphthoquinones
  • Quinones
  • Streptonigrin
  • L-Lactate Dehydrogenase
  • Daunorubicin